| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.051 | 0.08 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.074 | 0.09 |